THE WOODLANDS, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company primarily focused on the pediatric market, today announced that Cooper Collins, President and Chief Executive Officer, will present at the Piper Jaffray 23rd Annual Healthcare Conference on Tuesday, November 29, 2011 at 3:30 p.m. EST. The conference will be held at the New York Palace Hotel in New York.
